ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Fosaprepitant Dimeglumine Injection shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2026-04-08 · last update 2026-04-08

Manufacturers: Fresenius Kabi USA, LLC

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)Fresenius Kabi USA, LLCTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 04/08/2026
Updated 04/08/2026
Discontinued 04/08/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)